NASDAQ: SSNCSS&C Technologies Holdings Inc Stock
$73.55-2.78 (-3.64%)
Updated Apr 21, 2025
SSNC Price
$73.55
Fair Value Price
$60.61
Market Cap
$18.13B
52 Week Low
$60.01
52 Week High
$89.73
P/E
23.8x
P/B
2.77x
P/S
3.17x
PEG
0.83x
Dividend Yield
1.35%
Revenue
$5.88B
Earnings
$760.50M
Gross Margin
48.7%
Operating Margin
23.04%
Profit Margin
12.9%
Debt to Equity
1.9
Operating Cash Flow
$1B
Beta
0.99
Next Earnings
Apr 23, 2025
Ex-Dividend
N/A
Next Dividend
N/A
SSNC Overview
SS&C Technologies Holdings, Inc., together with its subsidiaries, provides software products and software-enabled services to financial services and healthcare industries. The company owns and operates technology stack across securities accounting; front-office functions, such as trading and modeling; middle-office functions include portfolio management and reporting; back-office functions, such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting; and healthcare solutions comprising claims adjudication, benefit management, care management, and business intelligence solutions. Its products and services allow professionals in the financial services and healthcare industries to automate complex business processes and are instrumental in helping its clients to manage information processing requirements. The company's software-enabled services include SS&C GlobeOp, Global Investor and Distribution Solutions, SS&C Retirement Solutions, Black Diamond Wealth Platform, Bluedoor, Advent Outsourcing Services, Advent Data Solutions, ALPS Advisors, and Virtual Data Rooms, as well as pharmacy, healthcare administration, and health outcomes optimization solutions. Its software products comprise portfolio/investment accounting and analytics software, portfolio management software, trading software, digital process automation product suite, and banking and lending solutions, as well as research, analytics, risk, and training solutions. The company also provides professional services, including consulting and implementation services to assist clients; and product support services. It operates in the United States; the United Kingdom; Europe, the Middle East, and Africa; the Asia Pacific and Japan; Canada; and the Americas. The company was founded in 1986 and is headquartered in Windsor, Connecticut.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SSNC's potential to beat the market
AStrong Buy
- Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important SSNC news, forecast changes, insider trades & much more!
SSNC News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SSNC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SSNC ($73.55) is overvalued by 21.35% relative to our estimate of its Fair Value price of $60.61 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SSNC ($73.55) is not significantly undervalued (21.35%) relative to our estimate of its Fair Value price of $60.61 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SSNC ($73.55) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more SSNC due diligence checks available for Premium users.
Valuation
SSNC fair value
Fair Value of SSNC stock based on Discounted Cash Flow (DCF)
Price
$73.55
Fair Value
$60.61
Overvalued by
21.35%
SSNC ($73.55) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SSNC ($73.55) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SSNC ($73.55) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SSNC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
23.8x
Industry
107.02x
Market
27.14x
SSNC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SSNC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SSNC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.77x
Industry
6.17x
SSNC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SSNC price to earnings growth (PEG)
For valuing profitable companies with growth potential
SSNC is good value based... subscribe to Premium to read more.
PEG Value Valuation
SSNC's financial health
Profit margin
Revenue
$1.5B
Net Income
$248.2M
Profit Margin
16.2%
SSNC's Earnings (EBIT) of $1.36B... subscribe to Premium to read more.
Interest Coverage Financials
SSNC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$19.0B
Liabilities
$12.4B
Debt to equity
1.9
SSNC's short-term assets ($4.86B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SSNC's long-term liabilities ($8.08B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SSNC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SSNC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$486.6M
Investing
-$53.1M
Financing
$637.8M
SSNC's operating cash flow ($1.39B)... subscribe to Premium to read more.
Debt Coverage Financials
SSNC vs App Stocks
SS&C Technologies Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.